Glaxosmithkline Share Price | |
---|---|
Price | 1,785.00 |
Bid | 1,784.50 |
Ask | 1,785.50 |
Change | 11.50 (0.65%) |
Volume | 1,072,005 |
Open | 1,780.00 |
High | 1,786.50 |
Low | 1,771.50 |
Prev. Close | 1,773.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.08b |
Market Capitalisation | £72.79b |
Market Size | 1,500 |
52 Week High | 1,786.50 |
52 Week High Date | 09-May-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 2,545 |
---|---|
Vol. Sold | 464,985 |
Sold Value | £8.26m |
Vol. Bought | 559,221 |
Bought Value | £9.95m |
PE Ratio | 14.67928 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.109% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
09-May-24 | 12:15:27 | 1,784.503 | 3 | Sell* | 1,784.50 | 1,785.50 | 53.54 | O Ordinary |
09-May-24 | 12:15:26 | 1,785.00 | 162 | Sell* | 1,785.00 | 1,785.50 | 2,892 | A Automatic Execution |
09-May-24 | 12:15:26 | 1,785.00 | 522 | Sell* | 1,785.00 | 1,785.50 | 9,318 | A Automatic Execution |
09-May-24 | 12:15:23 | 1,785.00 | 25 | Sell* | 1,785.00 | 1,785.50 | 446.25 | A Automatic Execution |
09-May-24 | 12:15:19 | 1,785.25 | 73 | Unknown* | 1,785.00 | 1,785.50 | 1,303 | O Ordinary |
09-May-24 | 12:15:07 | 1,785.50 | 370 | Sell* | 1,785.00 | 1,785.50 | 6,606 | A Automatic Execution |
09-May-24 | 12:15:07 | 1,785.50 | 262 | Sell* | 1,785.50 | 1,786.00 | 4,678 | A Automatic Execution |
09-May-24 | 12:15:07 | 1,785.50 | 167 | Sell* | 1,785.50 | 1,786.00 | 2,982 | A Automatic Execution |
09-May-24 | 12:15:07 | 1,785.50 | 110 | Sell* | 1,785.50 | 1,786.00 | 1,964 | A Automatic Execution |
09-May-24 | 12:15:07 | 1,785.50 | 290 | Sell* | 1,785.50 | 1,786.00 | 5,178 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Vishal Sikka held the position of Independent Non-Executive Director at the time of this trade.Vishal Sikka | 40.96 | USD | 43 | 253,466,508 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Jesse Goodman held the position of Independent Non-Executive Director at the time of this trade.Jesse Goodman | 40.96 | USD | 9 | 11,157 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
At GSK, we unite science, technology and talent to get ahead of disease together